Filing Details
- Accession Number:
- 0000014272-17-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-01 16:47:26
- Reporting Period:
- 2017-02-27
- Filing Date:
- 2017-03-01
- Accepted Time:
- 2017-03-01 16:47:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1688276 | Ii R. Theodore Samuels | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2017-02-27 | 12,000 | $56.77 | 12,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported reflects the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $56.765 to $56.81, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.